SCHEMBL4688100

SCHEMBL4688100

CCC1(CC)Cc2ccc(OC)cc2C1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.49
METAP1 P53582 3/20 0.49
ACHE P22303 3/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA4 P22748 1/20 0.45
CA7 P43166 1/20 0.45
CA9 Q16790 1/20 0.45
PPIB P23284 1/20 0.45
PDE3B Q13370 2/20 0.44
PDE3A Q14432 2/20 0.44
ALDH1A1 P00352 2/20 0.44
ADAM17 P78536 1/20 0.43
KDM4E B2RXH2 1/20 0.43
GLA P06280 1/20 0.43
HPGD P15428 1/20 0.43
HIF1A Q16665 1/20 0.43
MAPK14 Q16539 1/20 0.41
MAOB P27338 2/20 0.41
MAOA P21397 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25707425 0.88 BACE1 (0.53) BACE1METAP1ACHECA1CA2
SCHEMBL12746560 0.79 BACE1 (0.77) BACE1METAP1ACHECA1CA2
SCHEMBL2351080 0.79 METAP1 (0.53) METAP1ACHECA1CA2CA4
SCHEMBL30176810 0.79 METAP1 (0.53) METAP1ACHECA1CA2CA4
SCHEMBL8598650 0.78 PDE3B (0.44) METAP1ACHECA1CA2CA4
SCHEMBL7890030 0.78 L3MBTL1 (0.42) BACE1METAP1CA1CA2CA4
SCHEMBL19737862 0.78 METAP1 (0.51) BACE1METAP1ACHECA1CA2
SCHEMBL27188915 0.77 SMN1; SMN2 (0.47) BACE1METAP1ACHECA1CA2
SCHEMBL6800097 0.76 METAP1 (0.54) METAP1ACHECA1CA2CA4
SCHEMBL30834267 0.76 METAP1 (0.47) BACE1METAP1ACHECA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0885210-B2 Tricylic compounds having binding affinity for melatonin receptors, their production and use TAKEDA PHARMACEUTICAL (JP) 2008-06-18 EP disclosed
EP-1550655-A1 Bicyclic intermediates Takeda Pharmaceutical Company Limited (JP) 2005-07-06 EP disclosed
EP-0885210-B1 Tricylic compounds having binding affinity for melatonin receptors, their production and use TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2002-06-12 EP disclosed
EP-1199304-A1 Bicyclic compounds and pharmaceutical composition containing tricyclic compound for treating or preventing sleep disorders Takeda Chemical Industries, Ltd. (JP) 2002-04-24 EP disclosed
US-6218429-B1 TREATING MELATONIN RELATED DISORDERS (E.G. CIRCARDIAN RHYTHMS, SLEEP-AWAKE CYCLES, TIME ZONE CHANGES, SLEEP DISORDERS) TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-04-17 US disclosed
US-6034239-A BINDIG TO MELATONIN RECEPTORS; SLEEP DISORDERS; GLANDULAR DISORDERS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2000-03-07 US disclosed
EP-0885210-A1 Tricylic compounds having binding affinity for melatonin receptors, their production and use Takeda Chemical Industries, Ltd. (JP) 1998-12-23 EP disclosed
WO-1997032871-A1 TRICYCLIC COMPOUNDS, THEIR PRODUCTION AND USE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1997-09-12 WO disclosed